🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the effects of pioglitazone, once...
Status
Completed
Location
Multiple Locations
Start Date
2007-03
Trial ID
NCT00770497
Treatments Being Tested
This prospective multicenter, double blind study will evaluate the efficacy...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-11
Trial ID
NCT01042392
Treatments Being Tested
In addition to the blood pressure lowering effects of aliskiren, it may hav...
Status
Completed
Location
Novartis Investigator Site
Start Date
2009-05
Trial ID
NCT00923156
Treatments Being Tested
This study is designed to compare the blood pressure lowering efficacy of a...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-05
Trial ID
NCT01922141
Treatments Being Tested
The study is designed to primarily assess the effect of aliskiren on albumi...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2011-01
Trial ID
NCT01302899
This randomized placebo controlled double blind parallel clinical study wil...
Status
Recruiting
Location
Faculty of Pharmacy Tanta University
Start Date
2023-07-15
Trial ID
NCT05942053
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of LCZ696 ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-12-09
Trial ID
NCT02924727
This is a randomized controlled trial to evaluate the effect of ramipril in...
Status
Terminated
Location
Weill Cornell Medical College, Department of Urology
Start Date
2013-07
Trial ID
NCT01856361
The purpose of this study is to prevent major cardiovascular events (heart ...
Status
Completed
Location
Minneapolis Medical Research Foundation
Start Date
1999-09
Trial ID
NCT00000620
This is a randomized, double-blind, double-dummy, placebo-controlled, cross...
Status
Completed
Location
Toronto General Hospital
Start Date
2016-05-10
Trial ID
NCT02632747
Treatments Being Tested